Report
Oliver Metzger

Siemens Healthineers : Margin estimates reduced, Neutral rating maintained

>Imaging – reducing margin forecasts - The company has reduced its divisional margin forecast range again for FY 2021-22 with the release of its Q3 results, from 21-22% to 20-21%. The impact from inflationary headwinds and supply chain issues on the cost side is also more pronounced than we had estimated. We have therefore cut our FY 2021-22 adj. EBIT margin forecast from 21.0% to 20.1%. While management appears confident that pricing initiatives will help margins as...
Underlying
Siemens Healthineers AG

Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company is developing its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value. Siemens AG is a majority shareholder of the Company. The Company is active worldwide.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Oliver Metzger

ResearchPool Subscriptions

Get the most out of your insights

Get in touch